How Multicilin/Gemc1 co-opts these factors to strongly activate a program of gene expression required for MCC differentiation, while other E2F targets involved in cell cycle progression remain off, is still unclear. The gene discussed is MCIDAS; the disease is Merkel cell skin cancer.